Literature DB >> 13880901

Ribonuclease in normal and uraemic human blood.

J H CONNOLLY, R M HERRIOTT, S GUPTA.   

Abstract

Entities:  

Keywords:  RIBONUCLEASE/blood; UREMIA/blood

Mesh：

Substances：

Year:  1962        PMID： 13880901      PMCID： PMC2094312     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  22 in total

1.  Infectivity of ribonucleic acid from type I poliovirus in embryonated egg.

Authors:  I M MOUNTAIN; H E ALEXANDER
Journal:  Proc Soc Exp Biol Med       Date:  1959-07

2.  Deoxyribonuclease in human blood and platelets.

Authors:  J H CONNOLLY; R M HERRIOTT; S GUPTA
Journal:  Br J Exp Pathol       Date:  1962-08

3.  Inhibition of the infectivity of poliovirus ribonucleic acid by an interferon.

Authors:  M HO
Journal:  Proc Soc Exp Biol Med       Date:  1961-07

4.  A biological assay for ribonuclease with sub-millimicrogram sensitivity.

Authors:  J POLATNICK; H L BACHRACH
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

5.  The extraction of infectious virus nucleic acid with hot phenol.

Authors:  E WECKER
Journal:  Virology       Date:  1959-02       Impact factor: 3.616

6.  Biochemistry of viruses.

Authors:  L M KOZLOFF
Journal:  Annu Rev Biochem       Date:  1960       Impact factor: 23.643

7.  Infectivity of ribonucleic acid from Ehrlich ascites tumour cells infected with Mengo encephalitis.

Authors:  J S COLTER; H H BIRD; R A BROWN
Journal:  Nature       Date:  1957-04-27       Impact factor: 49.962

8.  The inhibition of ribonuclease.

Authors:  J C HOUCK
Journal:  Biochim Biophys Acta       Date:  1957-12

9.  Infectivity of ribonucleic acid isolated from virus-infected tissues.

Authors:  J S COLTER; H H BIRD; A W MOYER; R A BROWN
Journal:  Virology       Date:  1957-12       Impact factor: 3.616

10.  Infectivity of ribonucleic acid from tobacco mosaic virus.

Authors:  A GIERER; G SCHRAMM
Journal:  Nature       Date:  1956-04-14       Impact factor: 49.962
View more
  5 in total

1.  Serum ribonuclease activity in the diagnosis of pancreatic disease.

Authors:  T P Kemmer; P Malfertheiner; M Büchler; M L Kemmer; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991-01

2.  Fate of rubella genome ribonucleic acid after immune and nonimmune virolysis in the presence of ribonuclease.

Authors:  A Schluederberg; C Ajello; B Evans
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

3.  Assessment of the clinical usefulness of serum ribonuclease assays: an indicator for the detection of pancreatic cancer.

Authors:  H Nakane; M Yoshida; T Murakami
Journal:  Gastroenterol Jpn       Date:  1979

4.  [The value of poly-C-specific serum ribonuclease and CEA in the diagnosis of pancreatic carcinoma (author's transl)].

Authors:  N Hölbling; J Funovics; J Euler; J Karner; G Zöch; G Sauermann
Journal:  Klin Wochenschr       Date:  1981-11-02

5.  A mini DNA-RNA hybrid origami nanobrick.

Authors:  Lifeng Zhou; Arun Richard Chandrasekaran; Mengwen Yan; Vibhav A Valsangkar; Jeremy I Feldblyum; Jia Sheng; Ken Halvorsen
Journal:  Nanoscale Adv       Date:  2021-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.